HCW Biologics Announces Appointment of Two New Members to Board of Directors
New Members Add Depth to Board with Experience in Strategic Transactions, Strategy and Commercial Planning, and GovernanceMIRAMAR, Fla., Oct. 27,...
News
Kymera Therapeutics Presents Positive Data Demonstrating Robust IRAK4 Degradation and First Proof-of-Biology with Inhibition of Cytokine Induction from the Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers
Mean IRAK4 degradation of up to 96% in PBMC and up to 97% inhibition of ex vivo induction of multiple...
EyePoint Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 3, 2021
WATERTOWN, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and...
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore,...
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for Phase 1/1b Clinical Trial of Prexigebersen-A in Solid Tumors
Phase 1/1b Clinical Trial to Evaluate Ability of Prexigebersen-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and...
Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednesday, November 10 at 4:30 p.m. Eastern Time
DAVIS, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers...
Microbix Receives $2.7 Million from Exercise of Warrants
Further Capital to Assist with Increasing Capacity and EfficiencyMISSISSAUGA, Ontario, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
Sharps Compliance Reports Fiscal 2022 First Quarter Results
First quarter revenue of $13.9 million increased 6% from the prior yearRetail market billings increased 6% for the quarter Professional...
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the...
Teleflex Completes Enrollment in Cardiac IDE Study
Study Evaluates Effectiveness of QuikClot Control+® Hemostatic Device in Patients Undergoing Cardiac SurgeryWAYNE, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Teleflex...
SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Addition of New Sub-Studies to Existing Clinical Collaboration with GlaxoSmithKline Evaluating Nirogacestat in Combination with BLENREP in Patients with Relapsed or Refractory Multiple Myeloma
-- Based on Encouraging Preliminary Data Observed with the First Dose Exploration Cohort (0.95 mg/kg BLENREP Q3W + Nirogacestat) a...
NervGen Pharma Announces Spinal Cord Injury Clinical Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - October 27, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
Maitri Health Technologies Announces Name Change to Bloom Health Partners
Vancouver, British Columbia--(Newsfile Corp. - October 27, 2021) - Maitri Health Technologies Corp. (CSE: MTEC) (OTC Pink: MHTCF) (FSE: D84)...
Advice from a Sleep Physician to Successfully Deal with Fall’s Time Change and Reduced Daylight Hours
Calgary, Alberta--(Newsfile Corp. - October 27, 2021) - The clocks go back an hour at 02:00 AM Sunday morning November...
Limoneira Announces Appointment of Elizabeth Mora to Board of Directors
Seasoned Corporate Environmental Social and Governance (“ESG”) Professional SANTA PAULA, Calif.--(BUSINESS WIRE)--Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a...
NextGen Healthcare Partners with Validic to Incorporate New Remote Patient Monitoring Capabilities into NextGen Virtual Visits
NextGen Healthcare Client White House Clinics Leveraging New Functionality to Better Manage Patient Care ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq:...
Infostretch Partners with Snowflake to Optimize Analytics in the Cloud
SANTA CLARA, Calif.--(BUSINESS WIRE)--Infostretch has announced that it is partnering with Snowflake, the Data Cloud company, to allow enterprises to...
Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic(TM) and Other Nutraceutical Ingredients in U.S. and Mexico
Toronto, Ontario--(Newsfile Corp. - October 27, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...
‘For Hire’ Signs Are out at Pacific NW Life Science and Biotech Organizations – Career Match and Hiring Virtual Event on Nov. 10
PORTLAND, Ore.--(BUSINESS WIRE)--#NowHiring--Scores of jobs are open in the growing life science and biotech sectors in Oregon and southwest Washington,...
The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries
Merck, Ridgeback Biotherapeutics and Emory University Will Not Receive Royalties for Sales of Molnupiravir Under this Agreement for as Long...